Meng-Fen Wu

3.9k citations

43 papers · 2.6k indexed · 2 hit papers · h-index 24

Impact in

Oncology top 1%
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Viral-associated cancers and disorders
- Cancer Cells and Metastasis
Immunology top 5%
- Immune Cell Function and Interaction

Papers in

Transplantation 4
- Renal Transplantation Outcomes and Treatments 4
Oncology 29
- CAR-T cell therapy research 11
- Pancreatic and Hepatic Oncology Research 6

Co-authors: Susan G. HilsenbeckHao LiuHelen E. Heslop Malcolm K. Brenner Cliona M. Rooney Michael T. Lewis Catherine M. Bollard Karen S. Slobod
Journals: Blood (5 papers)Clinical Cancer Research (3 papers)Journal of Surgical Research (2 papers)HPB (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Germany China

In The Last Decade

Meng-Fen Wu

43 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma 2025 · 14 citations

Peers

Countries citing papers authored by Meng-Fen Wu

Since Specialization

Citations

This map shows the geographic impact of Meng-Fen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Fen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Fen Wu more than expected).

Fields of papers citing papers by Meng-Fen Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-Fen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Fen Wu. The network helps show where Meng-Fen Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Meng-Fen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meng-Fen Wu Line = papers co-authored together Meng-Fen Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Erianin isolated from Dendrobium huoshanense alleviated neuroinflammation in MPTP-induced Parkinson's disease model via NF-κB/NLRP3 pathway Journal of Ethnopharmacology ·Julia Pereira Figueiredo Freitas, Z. Ryan Tian, 上原偉男, Meng-Fen Wu, 朱惠珍 Chiung-Wen Chang, Zenggen Liu	2025	2
2	Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma Nature Medicine ·平山遼一, Sandhya Sharma, Andras Heczey, Mae Woods, Tom Kelly, Chrystal U. Louis, Bambi Grilley, Sachin G. Thakkar, Meng-Fen Wu, Tao Wang, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop Hit paper breakdown →	2025	14
3	Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant Transplantation and Cellular Therapy ·Ibrahim N. Muhsen, Syuan-Huei Horng, Tao Wang, Meng-Fen Wu, Premal Lulla, Carlos A. Ramos, Rammurti T. Kamble, Helen E. Heslop, George Carrum, LaQuisa Hill	2024	2
4	A High-Resolution Microendoscope Improves Esophageal Cancer Screening and Surveillance: Implications for Underserved Global Settings Based on an International Randomized Controlled Trial Gastroenterology ·Mimi C. Tan, Zhengqi Li, Kalpesh Patel, Fan Zhang, Xinying Yu, Anne Bates, Daniel Rosen, Sanford M. Dawsey, Liyan Xue, Martin J. Kühn, Richard A. Schwarz, Sam Carl, Rejanne LeBivic, Meng-Fen Wu, Tao Wang, Jennifer Carns, Hong Xu, Rebecca Richards‐Kortum, Guiqi Wang, 張孝徳	2024	1
5	LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study The Lancet Oncology ·Benjamin Musher, Eric K. Rowinsky, Brandon G. Smaglo, Wasif M. Abidi, Mohamed O. Othman, Farrukh Ijaz, Salmaan Jawaid, 知絵美菅, Jinghang Cong, Ann M. Leen, Meng-Fen Wu, Linda C. Sandin, Jessica Wenthe, Emma Eriksson, Gustav Ullenhag, Bambi Grilley, S Suhasinee, Susan G. Hilsenbeck, Malcolm K. Brenner, Angelica Loskog	2024	36
6	Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy Cytotherapy ·Yan Zhang, Iratxe Urkia-Susín, Sachin G. Thakkar, Meng-Fen Wu, José E. Rincón, Tao Wang, Bambi Grilley, Helen E. Heslop, Carlos A. Ramos, Margaret A. Goodell, Premal Lulla	2023	5
7	Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia Transplantation and Cellular Therapy ·Emily H. Wine, Syuan-Huei Horng, Meng-Fen Wu, Tao Wang, 郁子矢入, Erin Doherty, John Craddock, 信夫寺崎, Michelle Noteboom, M. E. E. Caluête, Anil George, Tom Kelly, Robert A. Krance, Caridad Martinez, Helen E. Heslop, Matt Ward	2023	4
8	Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting Clinical Cancer Research ·Thomas Pfeiffer, Ifigeneia Tzannou, Meng-Fen Wu, Carlos A. Ramos, Ghadir Sasa, Caridad Martinez, Premal Lulla, Robert A. Krance, 勝之山崎, Aine N. O’Sullivan, Swati Naik, Claire Bocchini, Francesco Autuori, Lasha Mikeladze, C. Kalfon, Tao Wang, Helen E. Heslop, Ann M. Leen, Bilal Omer	2023	49
9	Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas Blood ·LaQuisa Hill, Rayne H. Rouce, Meng-Fen Wu, Tao Wang, Royce Ma, Huimin Zhang, Birju Mehta, Natalia Lapteva, Zhuyong Mei, Tyler S. Smith, Lina Yang, Madhuwanti Srinivasan, 马振鹤, Carlos A. Ramos, Premal Lulla, Anaê Pavanatto, Bambi Grilley, Helen E. Heslop, Malcolm K. Brenner, Maksim Mamonkin	2023	30
10	Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma Bone Marrow Transplantation ·Brian D. Friend, Ibrahim N. Muhsen, Shreeya Patel, LaQuisa Hill, Premal Lulla, Carlos A. Ramos, Sai Ravi Pingali, Rammurti T. Kamble, Gerhad Lanuharsa, Matt Ward, Orcione Aparecida Vieira Pereira, Erin Doherty, John Craddock, Ghadir Sasa, Meng-Fen Wu, Tao Wang, Caridad Martinez, Robert A. Krance, Helen E. Heslop, George Carrum	2022	1
11	Phase I CAR-T Clinical Trials Review Anticancer Research ·Griffin JM, Meng-Fen Wu, Tao Wang	2022	6
12	Predicting Liver Allograft Discard Transplantation ·Abbas Rana, Kerstin Ludwig, Karim J. Halazun, 梁儒和, Meng-Fen Wu, Hao Liu, Michael Kueht, John M. Vierling, Norman Sussman, Ayse L. Mindikoglu, Tamir Miloh, Nhu Thao Nguyen Galván, Ronald T. Cotton, Christine A. O’Mahony, John A. Goss	2018	34
13	Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy: An Institutional Experience Biology of Blood and Marrow Transplantation ·Sarah E. Sartain, Olha Blagodir, Meng-Fen Wu, Olayimika Oyebanji, Jun Teruya, Robert A. Krance, Caridad Martinez	2018	23
14	Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma Neuro-Oncology ·Kevin Bielamowicz, Kristen Fousek, Tiara T. Byrd, Roger M. Walker, Malini Mukherjee, Nikita Aware, Meng-Fen Wu, Jordan S. Orange, Pavel Sumazin, Tsz‐Kwong Man, Sujith K. Joseph, Meenakshi Hegde, Nabil Ahmed	2017	339
15	Estrogen Promotes ER-Negative Tumor Growth and Angiogenesis through Mobilization of Bone Marrow–Derived Monocytes Cancer Research ·Vandana Iyer, Ina Klebba, Jessica McCready, Lisa M. Arendt, Isaki Bianca, Meng-Fen Wu, Xiaomei Zhang, Michael T. Lewis, Charlotte Kuperwasser	2012	42
16	Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease Journal of Allergy and Clinical Immunology ·Caridad Martinez, Sweta Shah, William T. Shearer, Howard M. Rosenblatt, Mary E. Paul, Javier Chinen, Kathryn Leung, Alana A. Kennedy‐Nasser, Malcolm K. Brenner, Helen E. Heslop, Hao Liu, Meng-Fen Wu, I. Celine Hanson, Robert A. Krance	2011	44
17	Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/neu-Overexpressing Breast Tumor Xenografts Clinical Cancer Research ·Mothaffar F. Rimawi, Lisa Wiechmann, Yen-Chao Wang, Catherine Huang, Ilenia Migliaccio, Meng-Fen Wu, Carolina Gutiérrez, Susan G. Hilsenbeck, Grazia Arpino, Suleiman Massarweh, Orlov Va, H. Geigenmuller, C. Kent Osborne, Rachel Schiff	2010	66
18	Drain data to predict clinically relevant pancreatic fistula HPB ·Daniel J. Moskovic, Sally E. Hodges, Meng-Fen Wu, F. Charles Brunicardi, Susan G. Hilsenbeck, William E. Fisher	2010	31
19	Preoperative Prediction of Complete Resection in Pancreatic Cancer Journal of Surgical Research ·Dhruvil Shah, William E. Fisher, Sally E. Hodges, Meng-Fen Wu, Susan G. Hilsenbeck, F. Charles Brunicardi	2008	21
20	Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms HPB ·William E. Fisher, Sally E. Hodges, Merfat Bibi, Muluken, Meng-Fen Wu, Susan G. Hilsenbeck, Isaac Raijman, F. Charles Brunicardi	2008	49

About Meng-Fen Wu

Meng-Fen Wu is a scholar working on Transplantation, Oncology, Hepatology, Hematology and Pathology and Forensic Medicine, having authored 43 papers that have together received 2.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Virus-based gene therapy research (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cytomegalovirus and herpesvirus research (5 papers), Renal Transplantation Outcomes and Treatments (4 papers), Pancreatitis Pathology and Treatment (4 papers), Hedgehog Signaling Pathway Studies (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (642 citations), Transplantation (72 citations), Genetics (537 citations) and Genetics (144 citations). Meng-Fen Wu has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Susan G. Hilsenbeck, Hao Liu, Helen E. Heslop, Malcolm K. Brenner, Cliona M. Rooney, Michael T. Lewis, Catherine M. Bollard, Karen S. Slobod, Gregory A. Hale and Colton A. Smith. Their work appears in journals such as Blood, Clinical Cancer Research, Journal of Surgical Research, HPB and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact